2026-08-07T09:17:34-05:00 2025-12-31 994625061 CRI ADVISORS LLC 7411 FULLERTON STREET SUITE 300 JACKSONVILLE FL 32256 990 2025-01-01 592624901 STOP CHILDREN'S CANCER INC STOP 3523772622 2622 NW 43RD STREET B3 GAINESVILLE FL 32606 LARRY HARTFIELD PRESIDENT 3523772622 2026-07-27 1 DANA ALEXANDER P01425283 9043566023 2026-07-27 2025 2025-03-06 01:10:19Z LARRY HARTFIELD 2622 NW 43RD STREET SUITE B3 GAINESVILLE FL 32606 1144772 0 X WWW.STOPCHILDRENSCANCER.ORG X 1981 FL THE MISSION OF STOP CHILDREN'S CANCER IS THE PREVENTION, CONTROL AND CURE OF CHILDHOOD CANCERS. FUNDS ARE RAISED ANNUALLY AND AWARDED TO SELECTED RESEARCH AGENCIES. 17 17 2 203 0 0 354221 559456 0 0 106231 97502 56995 99267 517447 756225 200000 430000 0 0 81955 81566 0 0 6281 39976 44087 321931 555653 195516 200572 1922828 2201322 2055 1631 1920773 2199691 X THE MISSION OF STOP CHILDREN'S CANCER IS THE PREVENTION, CONTROL AND CURE OF CHILDHOOD CANCERS. FUNDS ARE RAISED ANNUALLY AND AWARDED TO SELECTED RESEARCH AGENCIES. 0 0 517959 430000 SINCE ITS INCEPTION IN 1981, STOP CHILDREN'S CANCER HAS RAISED OVER $7 MILLION, INCLUDING THE BONNIE'S LEGACY ENDOWMENT FUND, WHICH HAS APPROXIMATELY $1 MILLION IN PERPETUITY. IN ADDITION, AS A RESULT OF THESE DONATIONS, WELL IN EXCESS OF $20 MILLION IN NATIONAL CANCER INSTITUTE/NATIONAL INSTITUTE OF HEALTH (NIH) GRANTS AND OTHER AWARDS HAVE BEEN RECEIVED. STOP CHILDREN'S CANCER / BONNIE R. FREEMAN CLINICAL TRIAL FUND:THIS FUND CONTINUES TO SUPPORT THE PROGRAM INFRASTRUCTURE, INCLUDING THE DIRECTOR'S POSITION, WHO HAS LED OUR EFFORTS TO GROW PEDIATRIC CANCER TRIALS. OVER THE 15 YEARS THAT THIS FUND HAS BEEN IN PLACE, MORE THAN 1,500 CLINICAL TRIALS HAVE BEEN CONDUCTED. STOP CHILDREN'S CANCER / KIMBERLY H. FLAITZ RESEARCH GRANT:THIS FUND HAS BEEN FOCUSED ON SUPPORTING RESEARCH ON EWING'S SARCOMA. THE TEAM, LED BY DR. ELIAS SAYOUR, HAS DEVELOPED FUSION-TARGETED MRNA VACCINE CONSTRUCTS THAT CAN NOW BE USED TO ADAPT FOR EWS-FL1 TARGETED INTERVENTION IN EWING'S SARCOMA. THE TEAM IS CONTINUING TO DEVELOP VACCINES TARGETING A SPECIFIC MUTATION FOUND IN EWING'S SARCOMA BUT NOT IN NORMAL CELLS, WITH THE HOPE OF OPENING A TRIAL WITHIN THE NEXT 4 YEARS. LYRICS FOR LIFE / STOP CHILDREN'S CANCER JEFFREY A. BLOCK RESEARCH GRANT:THIS FUNDING SUPPORTED DR. PAUL CASTILLO, WHO IS WORKING ON DEVELOPING NOVEL IMMUNOTHERAPIES TO TREAT REFRACTORY CANCERS, ESPECIALLY T-CELL LEUKEMIAS AND T-CELL LYMPHOMAS. GIVEN THE STRIKING RESULTS OF A COMBINATIONAL APPROACH USING CAR T CELLS AND RNA NANOPARTICLE-BASED VACCINES, HE CONTINUES TO USE THIS APPROACH, WHICH WAS REPORTED IN 2021. HE HAS SHOWN PROMISING DATA USING THIS IMMUNOTHERAPEUTIC COMBINATIONAL APPROACH FOR ACUTE MYELOID LEUKEMIA, METASTATIC OSTEOSARCOMA, AND METASTATIC MELANOMA. THE PROMISE OF THIS APPROACH IS THAT IT RETAINS ANTICANCER EFFICACY ACROSS A WIDE RANGE OF CANCERS. 517959 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 7 0 1 2 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 17 17 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 FL X HELEN C GIBBONS 3523772622 2622 NW 43RD STREET SUITE B3 GAINESVILLE FL 32606 X LARRY HARTFIELD PRESIDENT 1.00 X X 0 0 0 JIM BRANDENBURG VICE PRESIDENT 1.00 X X 0 0 0 JAMES QUESENBERRY VICE PRESIDENT 1.00 X X 0 0 0 LYNN BENNETT SECRETARY 1.00 X X 0 0 0 CINDY SMYDER TREASURER 1.00 X X 0 0 0 JAMES ROBERTSON IMMEDIATE PAST PRESIDENT 1.00 X 0 0 0 PHYLLIS BAUCOM BOARD MEMBER 1.00 X 0 0 0 JIM CARNES BOARD MEMBER 1.00 X 0 0 0 BECKY DE MARIE BOARD MEMBER 1.00 X 0 0 0 PAT DOOLEY BOARD MEMBER 1.00 X 0 0 0 BETH FLAITZ BOARD MEMBER 1.00 X 0 0 0 CAROLYNE R FREEMAN BOARD MEMBER 1.00 X 0 0 0 HOWARD FREEMAN BOARD MEMBER 1.00 X 0 0 0 LAUREL FREEMAN BOARD MEMBER 1.00 X 0 0 0 JAY HUTTO BOARD MEMBER 1.00 X 0 0 0 MARC SPIWAK BOARD MEMBER 1.00 X 0 0 0 MARY ANNE WESTPHAL BOARD MEMBER 1.00 X 0 0 0 0 0 0 0 0 0 0 0 227294 332162 61406 559456 87229 87229 296981 286708 10273 10273 10273 201106 227294 101839 99267 99267 756225 0 0 196769 430000 430000 75761 53033 18940 3788 5805 4063 1452 290 2857 2000 714 143 6407 4485 1602 320 537 376 134 27 8563 5995 2140 428 348 244 87 17 2919 2043 730 146 5604 3923 1401 280 3465 2426 866 173 DUES & SUBSCRIPTIONS 12892 9024 3223 645 MERCHANDISE 495 347 124 24 555653 517959 31413 6281 322480 10855 533881 159014 72123 92495 86891 1507853 1569695 1922828 2201322 2055 0 0 1631 2055 1631 X 1920773 2199691 1920773 2199691 1922828 2201322 200572 78346 0 X 0 0 0 X 211431 381819 549651 354221 559456 2056578 211431 381819 549651 354221 559456 2056578 2056578 39355 34863 42281 106232 97502 320233 196630 201105 397735 2774546 0.74120 0.78030 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 140000 57750 82250 19014 14373 4641 86891 PAYROLL LIABILITIES 1631 1631 FANTASY EVENT 131511 112711 18800 4974 24862 5250 16762 GOLF CLASSIC 133536 92526 41010 16872 6960 14122 3064 5 163353 22057 141296 300 2417 6256 428400 227294 201106 16872 12234 41401 5250 26082 101839 99267 1 UNIVERISITY OF FLORIDA FOUNDATION PO BOX 14425 GAINESVILLE FL 32604 590974739 501(C)(3) 400000 0 TO FUND SALARY IN THE PEDIATRIC CLINICAL TRIAL PROGRAMS AND FUND RESEARCH OF CHILDHOOD CANCERS AT THE UNIVERSITY OF FLORIDA. CAMP BOGGY CREEK 30500 BRANTLEY BRANCH RD EUSTIS FL 32736 593012889 501(C)(3) 30000 0 FUNDING FOR SUMMER NURSES 2025, 2 CAMPS PART I, LINE 2: BOARD OF DIRECTORS RECEIVES SCHEDULED PROGRESS REPORTS WITH REGARD TO THE RESEARCH FUNDED BY THE GRANT. X 9 9539 FAIR MARKET VALUE X OTHER 6 51867 FAIR MARKET VALUE 0 1 0 FORM 990, PART VI, SECTION A, LINE 2 HOWARD FREEMAN - DIRECTOR AND LAUREL FREEMAN - DIRECTOR ARE SPOUSES CAROLYNE FREEMAN - DIRECTOR IS THE DAUGHTER OF LAUREL FREEMAN - DIRECTOR CAROLYNE FREEMAN - DIRECTOR IS THE DAUGHTER OF HOWARD FREEMAN - DIRECTOR FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE 990 IS PROVIDED TO THE PRESIDENT AND TREASURER PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY BY REQUIRING ANY DIRECTOR TO DISCLOSE IF THERE IS A CONFLICT PRIOR TO VOTING ON ANY GIVEN ISSUE. FORM 990, PART VI, SECTION B, LINE 15 WHEN NECESSARY, THE EXECUTIVE COMMITTEE APPOINTS A REVIEW COMMITTEE TO REVIEW COMPENSATION PACKAGES. THE REVIEW COMMITTEE WILL THEN BRING BACK FINDINGS TO THE EXECUTIVE COMMITTEE FOR DISCUSSION. AFTER THIS REVIEW, THE COMPENSATION PACKAGES WOULD BE BROUGHT TO THE FULL BOARD TO BE VOTED ON AND APPROVED. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST.